Related Experiment Video

Updated: Jun 16, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Five steps for structural reform in clinical cancer research

Alastair Matheson1

  • 1amathesonresearch@gmail.com

American Journal of Public Health
|February 20, 2010
PubMed

Insights

Clinical cancer research faces challenges despite advances. Optimizing research structures and collaboration among government, industry, and academia is crucial for future treatment breakthroughs.

Area of Science:

  • Oncology
  • Clinical Research
  • Medical Innovation

Background:

  • Despite progress in cancer prevention, early detection, and treatment, clinical research has not matched the impact of earlier breakthroughs like imatinib.
  • Significant scientific hurdles and structural inefficiencies impede research progress.
  • Current research organization, regulation, and conduct require optimization.

Purpose of the Study:

  • To identify key impediments in clinical cancer research.
  • To propose necessary adjustments in the roles of various stakeholders to optimize the research environment.
  • To outline a strategy for enhancing research efficiency and maximizing funding benefits.

Main Methods:

  • Analysis of existing clinical research structures and their deficiencies.
  • Review of the roles and interactions of government, industry, academia, and regulatory bodies.
  • Synthesis of potential reforms and their enabling characteristics.

Main Results:

  • Identified scientific and structural deficiencies as primary barriers to progress.
  • Highlighted the need for coordinated adjustments in stakeholder roles.
  • Proposed that enabling reforms, building on existing expertise, can yield substantial progress.

Conclusions:

  • Optimizing the clinical cancer research environment requires systemic adjustments.
  • Collaboration and redefined roles among government, industry, academia, and regulatory authorities are essential.
  • Targeted, enabling reforms can significantly advance cancer treatment development without radical intervention.

More Related Videos

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.